VEGF Trap-Eye was not approved by the FDA for the treatment of wet macular degeneration. The parent company, Regeneron, was hopeful to gain FDA approval last week, but the FDA delayed its decision until November of this year.
VEGF Trap-Eye Treats Wet Macular Degeneration
VEGF Trap-Eye, or aflibercept, is another anti-VEGF drug formulated to treat wet macular degeneration.
Like its competitors, aflibercept is designed to neutrali (Read more...)